0001666071-22-000034.txt : 20220405 0001666071-22-000034.hdr.sgml : 20220405 20220405165506 ACCESSION NUMBER: 0001666071-22-000034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220401 FILED AS OF DATE: 20220405 DATE AS OF CHANGE: 20220405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Grimes Scott D. CENTRAL INDEX KEY: 0001617486 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38386 FILM NUMBER: 22807811 MAIL ADDRESS: STREET 1: CARDLYTICS, INC. STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardlytics, Inc. CENTRAL INDEX KEY: 0001666071 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 263039436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 BUSINESS PHONE: 888-798-5802 MAIL ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 4 1 wf-form4_164919208996206.xml FORM 4 X0306 4 2022-04-01 0 0001666071 Cardlytics, Inc. CDLX 0001617486 Grimes Scott D. C/O CARDLYTICS, INC. 675 PONCE DE LEON AVENUE NE, SUITE 6000 ATLANTA GA 30308 1 0 0 0 Common Stock 2022-04-01 4 M 0 14920 0 A 230608 D Common Stock 2022-04-04 4 S 0 2500 56.40 D 228108 D Common Stock 2022-04-04 4 S 0 3100 57.40 D 225008 D Common Stock 2022-04-04 4 S 0 400 58.09 D 224608 D Common Stock 53112 I See Footnote Common Stock 55832 I See Footnote Restricted Stock Units 2022-04-01 4 M 0 14920 0 D Common Stock 14920.0 29840 D Represents the underlying vested shares of common stock of the Issuer which have not been delivered. These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2020, as amended September 15, 2021. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $55.91 to $56.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5) to this Form 4. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $56.93 to $57.90, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $58.05 to $58.17, inclusive. The reportable securities are held by the 2013 Scott Grimes GRAT UAD. The reportable securities are held by the UTMA Custodial account fbo Pierce Grimes. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent. The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date. /s/ Kirk Somers, Attorney-in-Fact 2022-04-05